What did Quanterix Corporation pay for Akoya Biosciences, Inc.?

Quanterix Corporation acquired Akoya Biosciences, Inc. for $286.0M in 2025, equivalent to 3.30x revenue. Target revenue was approximately $86.0M.

What does Akoya Biosciences, Inc. do?

Akoya Biosciences, Inc. is a laboratory services business.

What multiple did Quanterix Corporation pay for Akoya Biosciences, Inc.?

3.30x revenue, based on disclosed deal value of $286.0M and disclosed financials.

M&A TRANSACTION · 2025

Akoya Biosciences, Inc. acquired by Quanterix Corporation

$286.0M· 3.30x revenue

Target

Akoya Biosciences, Inc.

Acquirer

Quanterix Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$86.0M

EBITDA

—

Deal Value

$286.0M

EV/EBITDA

—

Context

This $286.0M acquisition of Akoya Biosciences, Inc. by Quanterix Corporation sits in the laboratory services sub-vertical. Quanterix Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Akoya Biosciences, Inc. acquisition.

Citation: ExitValue.ai. (2025). Akoya Biosciences, Inc. acquired by Quanterix Corporation. https://exitvalue.ai/deals/akoya-biosciences-inc-acquired-by-quanterix-corporation-fairness-opi